Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousMonocrotophosTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsBlood BanksGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Bone Marrow TransplantationMelphalanGranulocyte Colony-Stimulating FactorGraft SurvivalLeukapheresisCombined Modality TherapyTreatment OutcomeTransplantation ChimeraCell DifferentiationBusulfanMultiple MyelomaMyeloablative AgonistsTissue DonorsCyclophosphamideBlood Component RemovalRecurrenceAntineoplastic Combined Chemotherapy ProtocolsRemission InductionMice, SCIDWhole-Body IrradiationHistocompatibility TestingCells, CulturedLiver TransplantationHistocompatibilityLymphoma, Non-HodgkinLeukemiaAntineoplastic Agents, AlkylatingRetrospective StudiesImmunosuppressive AgentsDisease-Free SurvivalMesenchymal Stem Cell TransplantationVidarabineEtoposideThiotepaHematopoiesisGraft vs Leukemia EffectSurvival RateInfectionSalvage TherapySurvival AnalysisTime FactorsCell TransplantationTransplantation, IsogeneicLeukemia, Myeloid, AcuteHematologic DiseasesPOEMS SyndromeEmbryonic Stem CellsKidney TransplantationHodgkin DiseaseAmyloidosisBlood CellsCytarabineSpinal CordMyelodysplastic SyndromesAdult Stem CellsVincristineHLA AntigensCarmustineFollow-Up StudiesAnemia, AplasticCytomegalovirus InfectionsLymphomaMice, Inbred NODLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaFatal OutcomeLymphocyte DepletionIfosfamidePlatelet CountTransplantation ImmunologyImmunosuppressionBlood Transfusion, AutologousCyclosporinePluripotent Stem CellsNeoplasmsBlood DonorsImmunophenotypingBlood Cell CountHeart TransplantationGraft vs Tumor EffectBone Marrow CellsProspective StudiesT-Lymphocytes